Amgen Delivers On Launch Of First US Humira Rival – At A 55% Discount

Amjevita Biosimilar Version Of Adalimumab Has Six Months With The Market To Itself

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.